Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

1.

Exploring Alzheimer Molecular Pathology in Down's Syndrome Cerebrospinal Fluid.

Portelius E, Soininen H, Andreasson U, Zetterberg H, Persson R, Karlsson G, Blennow K, Herukka SK, Mattsson N.

Neurodegener Dis. 2014 Jun 27. [Epub ahead of print]

PMID:
24992945
[PubMed - as supplied by publisher]
2.

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease.

Mielke MM, Haughey NJ, Bandaru VV, Zetterberg H, Blennow K, Andreasson U, Johnson SC, Gleason CE, Blazel HM, Puglielli L, Sager MA, Asthana S, Carlsson CM.

Neurobiol Aging. 2014 May 27. pii: S0197-4580(14)00382-0. doi: 10.1016/j.neurobiolaging.2014.05.019. [Epub ahead of print]

PMID:
24952994
[PubMed - as supplied by publisher]
3.

Mass spectrometry-based candidate reference measurement procedure for quantification of amyloid-β in cerebrospinal fluid.

Leinenbach A, Pannee J, Dülffer T, Huber A, Bittner T, Andreasson U, Gobom J, Zetterberg H, Kobold U, Portelius E, Blennow K; IFCC Scientific Division Working Group on CSF proteins.

Clin Chem. 2014 Jul;60(7):987-94. doi: 10.1373/clinchem.2013.220392. Epub 2014 May 19.

PMID:
24842955
[PubMed - indexed for MEDLINE]
4.

CSF Aβ42 predicts early-onset dementia in Parkinson disease.

Alves G, Lange J, Blennow K, Zetterberg H, Andreasson U, Førland MG, Tysnes OB, Larsen JP, Pedersen KF.

Neurology. 2014 May 20;82(20):1784-90. doi: 10.1212/WNL.0000000000000425. Epub 2014 Apr 18.

PMID:
24748671
[PubMed - indexed for MEDLINE]
5.

Blood-cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment.

Zetterberg H, Jakobsson J, Redsäter M, Andreasson U, Pålsson E, Ekman CJ, Sellgren C, Johansson AG, Blennow K, Landén M.

Psychiatry Res. 2014 Jul 30;217(3):143-6. doi: 10.1016/j.psychres.2014.03.045. Epub 2014 Apr 5.

PMID:
24745469
[PubMed - in process]
6.

CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.

Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A.

Parkinsonism Relat Disord. 2014 Apr;20(4):382-7. doi: 10.1016/j.parkreldis.2014.01.011. Epub 2014 Jan 22.

PMID:
24507721
[PubMed - in process]
7.

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

Johansson P, Almqvist EG, Johansson JO, Mattsson N, Andreasson U, Hansson O, Wallin A, Blennow K, Zetterberg H, Svensson J.

PLoS One. 2013 Nov 29;8(11):e81989. doi: 10.1371/journal.pone.0081989. eCollection 2013.

PMID:
24312390
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Cerebrospinal fluid biomarkers in cardiac arrest survivors.

Rosén C, Rosén H, Andreasson U, Bremell D, Bremler R, Hagberg L, Rosengren L, Blennow K, Zetterberg H.

Resuscitation. 2014 Feb;85(2):227-32. doi: 10.1016/j.resuscitation.2013.10.032. Epub 2013 Nov 11.

PMID:
24231570
[PubMed - in process]
9.

Lipopolysaccharide-induced inflammation aggravates irradiation-induced injury to the young mouse brain.

Roughton K, Andreasson U, Blomgren K, Kalm M.

Dev Neurosci. 2013;35(5):406-15. doi: 10.1159/000353820. Epub 2013 Aug 20.

PMID:
23970040
[PubMed - indexed for MEDLINE]
10.

Cerebrospinal fluid brain injury biomarkers in children: a multicenter study.

Shahim P, Darin N, Andreasson U, Blennow K, Jennions E, Lundgren J, Månsson JE, Naess K, Törnhage CJ, Zetterberg H, Mattsson N.

Pediatr Neurol. 2013 Jul;49(1):31-39.e2. doi: 10.1016/j.pediatrneurol.2013.02.015.

PMID:
23827424
[PubMed - indexed for MEDLINE]
11.

Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's disease.

Hölttä M, Hansson O, Andreasson U, Hertze J, Minthon L, Nägga K, Andreasen N, Zetterberg H, Blennow K.

PLoS One. 2013 Jun 14;8(6):e66381. doi: 10.1371/journal.pone.0066381. Print 2013.

PMID:
23799095
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

CSF biomarker variability in the Alzheimer's Association quality control program.

Mattsson N, Andreasson U, Persson S, Carrillo MC, Collins S, Chalbot S, Cutler N, Dufour-Rainfray D, Fagan AM, Heegaard NH, Robin Hsiung GY, Hyman B, Iqbal K, Lachno DR, Lleó A, Lewczuk P, Molinuevo JL, Parchi P, Regeniter A, Rissman R, Rosenmann H, Sancesario G, Schröder J, Shaw LM, Teunissen CE, Trojanowski JQ, Vanderstichele H, Vandijck M, Verbeek MM, Zetterberg H, Blennow K, Käser SA; Alzheimer's Association QC Program Work Group.

Alzheimers Dement. 2013 May;9(3):251-61. doi: 10.1016/j.jalz.2013.01.010.

PMID:
23622690
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Plasma tau levels in Alzheimer's disease.

Zetterberg H, Wilson D, Andreasson U, Minthon L, Blennow K, Randall J, Hansson O.

Alzheimers Res Ther. 2013 Mar 28;5(2):9. doi: 10.1186/alzrt163. eCollection 2013. No abstract available.

PMID:
23551972
[PubMed]
Free PMC Article
14.

Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.

Brinkmalm G, Brinkmalm A, Bourgeois P, Persson R, Hansson O, Portelius E, Mercken M, Andreasson U, Parent S, Lipari F, Ohrfelt A, Bjerke M, Minthon L, Zetterberg H, Blennow K, Nutu M.

Brain Res. 2013 Jun 4;1513:117-26. doi: 10.1016/j.brainres.2013.03.019. Epub 2013 Mar 27.

PMID:
23541617
[PubMed - indexed for MEDLINE]
15.

CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.

Andreasson U, Lautner R, Schott JM, Mattsson N, Hansson O, Herukka SK, Helisalmi S, Ewers M, Hampel H, Wallin A, Minthon L, Hardy J, Blennow K, Zetterberg H.

Mol Psychiatry. 2014 Feb;19(2):148-9. doi: 10.1038/mp.2013.18. Epub 2013 Feb 19. No abstract available.

PMID:
23419830
[PubMed - in process]
Free PMC Article
16.

Complement gene single nucleotide polymorphisms and biomarker endophenotypes of Alzheimer's disease.

Daborg J, Holmgren S, Abramsson A, Andreasson U, Zetterberg M, Nilsson S, Minthon L, Skoog I, Blennow K, Pekna M, Hanse E, Zetterberg H.

J Alzheimers Dis. 2013;35(1):51-7. doi: 10.3233/JAD-121930.

PMID:
23313922
[PubMed - indexed for MEDLINE]
17.

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.

Bremell D, Mattsson N, Edsbagge M, Blennow K, Andreasson U, Wikkelsö C, Zetterberg H, Hagberg L.

BMC Neurol. 2013 Jan 7;13:2. doi: 10.1186/1471-2377-13-2.

PMID:
23294475
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Aβ1-15/16 as a potential diagnostic marker in neurodegenerative diseases.

Nutu M, Bourgeois P, Zetterberg H, Portelius E, Andreasson U, Parent S, Lipari F, Hall S, Constantinescu R, Hansson O, Blennow K.

Neuromolecular Med. 2013 Mar;15(1):169-79. doi: 10.1007/s12017-012-8208-8. Epub 2012 Dec 7.

PMID:
23225274
[PubMed - indexed for MEDLINE]
19.

Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.

Alves G, Pedersen KF, Bloem BR, Blennow K, Zetterberg H, Borm GF, Dalaker TO, Beyer MK, Aarsland D, Andreasson U, Lange J, Tysnes OB, Zivadinov R, Larsen JP.

J Neurol Neurosurg Psychiatry. 2013 May;84(5):537-43. doi: 10.1136/jnnp-2012-303808. Epub 2012 Oct 31.

PMID:
23117496
[PubMed - indexed for MEDLINE]
20.

Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.

Augutis K, Axelsson M, Portelius E, Brinkmalm G, Andreasson U, Gustavsson MK, Malmeström C, Lycke J, Blennow K, Zetterberg H, Mattsson N.

Mult Scler. 2013 Apr;19(5):543-52. doi: 10.1177/1352458512460603. Epub 2012 Oct 15.

PMID:
23069872
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk